CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ito, M.
Right arrow Articles by Matsui, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ito, M.
Right arrow Articles by Matsui, T.

Cell Growth & Differentiation, Vol 5, Issue 10 1127-1135, Copyright © 1994 by American Association of Cancer Research


ARTICLES

Functional characterization of two cholecystokinin-B/gastrin receptor isoforms: a preferential splice donor site in the human receptor gene

M Ito, N Iwata, T Taniguchi, T Murayama, K Chihara and T Matsui
Department of Medicine, Kobe University School of Medicine, Japan.

The cholecystokinin-B and gastrin receptor is encoded by a single gene composed of five exons and spanning over 10 kilobases on human chromosome 11p 15.5-->15.4. Exon 4 has two possible alternative splicing donor sites that seem to be conserved in other species such as the canine, rat, Mastomys, and mouse. They could generate two receptor isoforms (short- and long-form), which differ in their putative third cytoplasmic domain of the serpentine G-protein-coupled receptors. In the present study, we examined whether an alternative splicing is operated in a tissue-specific manner and whether two receptor isoforms have functional differences. RNase-protection assay and S1 nuclease mapping demonstrated the preferential expression of the short-form in the human brain as well as the digestive organs, stomach and pancreas. The two putative isoforms of the cholecystokinin-B/gastrin receptor expressed in mouse fibroblasts showed the same characteristics in their ligand-bindings, the major signal transduction such as phosphoinositides production, cytoplasmic Ca2+ increase, tyrosine phosphorylation of focal adhesion kinase, activation of mitogen-activated protein kinase, and the induction of early-responsive genes such as c-fos, c-myc, and c-jun. Moreover, the ligand-dependent trophic effect was seen in both receptor isoforms. Taken together with the absence of tissue-specific expression of two receptor isoforms, these results suggest a species-specific dominant splice donor site in exon 4 of the human receptor gene.


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
M. Dufresne, C. Seva, and D. Fourmy
Cholecystokinin and gastrin receptors.
Physiol Rev, July 1, 2006; 86(3): 805 - 847.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
L. Aloj, C. Caraco, M. Panico, A. Zannetti, S. Del Vecchio, D. Tesauro, S. De Luca, C. Arra, C. Pedone, G. Morelli, et al.
In Vitro and In Vivo Evaluation of 111In-DTPAGlu-G-CCK8 for Cholecystokinin-B Receptor Imaging
J. Nucl. Med., March 1, 2004; 45(3): 485 - 494.
[Abstract] [Full Text]


Home page
GutHome page
S A Watson, T M Morris, A Varro, D Michaeli, and A M Smith
A comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growth
Gut, December 1, 1999; 45(6): 812 - 817.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
F. Noble, S. A. Wank, J. N. Crawley, J. Bradwejn, K. B. Seroogy, M. Hamon, and B. P. Roques
International Union of Pharmacology. XXI. Structure, Distribution, and Functions of Cholecystokinin Receptors
Pharmacol. Rev., December 1, 1999; 51(4): 745 - 781.
[Full Text] [PDF]


Home page
GutHome page
D F McWilliams, S A Watson, D M Crosbee, D Michaeli, and R Seth
Coexpression of gastrin and gastrin receptors (CCK-B and Delta CCK-B) in gastrointestinal tumour cell lines
Gut, June 1, 1998; 42(6): 795 - 798.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Oiry, D. Gagne, E. Cottin, N. Bernad, J.-C. Galleyrand, G. Berge, M.-F. Lignon, P. Eldin, M. Le Cunff, J. Leger, et al.
CholecystokininB Receptor from Human Jurkat Lymphoblastic T Cells Is Involved in Activator Protein-1-Responsive Gene Activation
Mol. Pharmacol., August 1, 1997; 52(2): 292 - 299.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1994 by the American Association of Cancer Research.